InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
ACO | Ann: Removal from the official list of ASX | 15/10/18 | 0 | 157 | |||
|
|||||||
ACO | Ann: Update regarding Administration | 21/09/18 | 0 | 163 | |||
|
|||||||
ACO | Ann: Suspension Announcement - System Upgrade | 06/08/18 | 0 | 209 | |||
|
|||||||
ACO | Ann: Suspension Announcement - System Upgrade | 06/08/18 | 0 | 141 | |||
|
|||||||
ACO | Ann: Update regarding Administration-ACO.AX | 09/01/17 | 5 | 3.6K | |||
|
|||||||
ACO | Ann: Update regarding Administration | 22/11/16 | 0 | 509 | |||
|
|||||||
ACO | Ann: Deferral of Financial Reporting & AGM Requirements-ACO.AX | 21/09/16 | 0 | 497 | |||
|
|||||||
ACO | Ann: Update regarding Administration-ACO.AX | 12/08/16 | 0 | 771 | |||
|
See All Discussions